$4.25
-0.03-0.70%
At Close: -
$4.25
00.00%
After Hours: Sep 20, 4:10 PM EDT
15 minutes delayed
Comments
Loading...
Mereo BioPharma Group (NASDAQ:MREO) Stock, Earnings Estimates, EPS, And Revenue
Mereo BioPharma Group reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Nov 13
EPS Estimate
$-0.020
Quarterly Revenue Estimate
–
Annual Revenue
(as of Jun 30)
(as of Jun 30)
$1M
Analyze the earnings history of Mereo BioPharma Group using advanced sorting and filters.
Data brought to you by Benzinga APIs
Mereo BioPharma Group (MREO) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
Mereo BioPharma Group (MREO) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
FAQ
When is Mereo BioPharma Group (NASDAQ:MREO) reporting earnings?
Mereo BioPharma Group (MREO) is scheduled to report earnings on November 13, 2024. The last reported earnings were for reported on August 13, 2024 for Q2.
What were the latest earnings per share (EPS) for Mereo BioPharma Group (NASDAQ:MREO)?
The Actual EPS was $-0.02, which missed the estimate of $0.00.
What were Mereo BioPharma Group’s (NASDAQ:MREO) revenues?
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.